Showing results (161-170 of 239) with videos related to
Sort By:
Pageof 24
Thrombosis and Haemostasis|June 24, 1985
The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal womenI D Walker, J F Davidson, A Richards, et al.The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restrictionN Sattar, I A Greer, P J Galloway, et al.Thrombosis and Haemostasis|February 12, 1999
A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancyN Sattar, I A Greer, A Rumley, et al.Thrombosis and Haemostasis|September 1, 1996
Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of international normalised ratio: a thirty-three-laboratory collaborative study. The Steering Committee of the UK National External Quality Assessment Scheme for Blood CoagulationS Kitchen, I Jennings, T A Woods, et al.Molecular Human Reproduction|October 25, 2000
Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturitionM A Ledingham, A J Thomson, A Young, et al.Molecular Human Reproduction|March 5, 1999
Myometrial constitutive nitric oxide synthase expression is increased during human pregnancyJ E Norman, A J Thompson, J F Telfer, et al.British Journal of Obstetrics and Gynaecology|February 1, 1992
Doppler umbilical artery flow velocity waveforms in diabetic pregnancyF D Johnstone, J M Steel, N G Haddad, et al.Obstetrics and Gynecology|December 1, 1989
Increased neutrophil activation in diabetic pregnancy and in nonpregnant diabetic womenI A Greer, N G Haddad, J Dawes, et al.Clinical and Laboratory Haematology|January 1, 1986
Co-incidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulinD Maharaj, I D Walker, H P McEwan, et al.The Journal of Biological Chemistry|May 25, 1987
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagenJ F Bateman, D Chan, I D Walker, et al.Pageof 24